Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide

The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel

(2010) Qian Liu et al.   BMC Medical Genomics

Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro

(2010) Sabyasachi Biswas et al.   LEUKEMIA RESEARCH

γ-Glutamyltransferase-dependent resistance to arsenic trioxide in melanoma cells and cellular sensitization by ascorbic acid

(2009) Chiara Giommarelli et al.   FREE RADICAL BIOLOGY AND MEDICINE

Global effects of inorganic arsenic on gene expression profile in human macrophages

(2009) Emilie Bourdonnay et al.   MOLECULAR IMMUNOLOGY

Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism

(2008) Benjamin D. Bowling et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen

(2008) S. A. Amundson et al.   CANCER RESEARCH

Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels

(2008) Yong Hwan Han et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Catalase activity and arsenic sensitivity in acute leukemia

(2008) Emma Coe et al.   LEUKEMIA & LYMPHOMA

Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy

(2008) Kathryn F. Tonissen et al.   MOLECULAR NUTRITION & FOOD RESEARCH

As2O3-induced oxidative stress and cycle progression in a human intestinal epithelial cell line (Caco-2)

(2007) J.M. Laparra et al.   TOXICOLOGY IN VITRO